Tag: Abbott
Abbott to separate Nutrition business, position it to scale
October 22, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott plans to separate its nutrition business into an independent, publicly traded company with approximately $8.5 billion in annual sales.
"As we continue to shape Abbott for the future, this separation will benefit both companies, setting each one up for maximum success in its respective market," said Robert B. Ford, chairman and CEO, Abbott. "Our Nutrition business has a unique opportunity to capitalize on the growing demand for healthy nutrition,...
Abbott, Berry Street partner to launch proactive approach to nutrition
September 24, 2026HME News Staff
PARK, Ill. and NEW YORK – Abbott and Berry Street have partnered to help people take a more proactive approach to nutrition and long-term health. The partnership brings together Lingo, Abbott's over-the-counter biowearable that provides personal glucose insights, with live nutrition coaching from Berry Street, one of the nation's largest insurance-covered nutrition care platforms, helping consumers turn metabolic insights into meaningful action. "At Abbott, we believe the...
In brief: MA fraud, Abbott settlement, MiniMed separation, SoClean commercial
September 16, 2026HME News Staff
WASHINGTON – The Office of Inspector General (OIG) says it has identified gaps in the screening process for fraudulent DMEPOS suppliers in Medicare Advantage.
The agency issued a report on Sept. 9 saying Medicare Advantage organizations (MAOs) conduct some screening checks on in-network suppliers but fewer checks of out-of-network suppliers. It also says:
The Centers for Medicare & Medicaid Services (CMS) does not screen all DEMPOS suppliers before they bill Medicare Advantage because...
Abbott agrees to pay $385M to settle infant formula case
September 15, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott will pay $385 million to resolve a previously disclosed investigation and lawsuit brought by the U.S. Department of Justice (DOJ), as well as lawsuits filed by certain relators and the attorneys general of several states, relating to its 2022 recall of powdered infant formula manufactured at its Sturgis, Mich., facility.
The settlement, the company says, does not represent any finding of fault or liability.
Abbott also noted, in relation to the settlement:
The...
Abbott gets FDA clearance for dual sensing technology
August 27, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott has received U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day system, a dual glucose ketone sensing technology. The new biowearable is designed to alert people living with diabetes of rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency, a serious health complication for people with diabetes. "As a physician, I see how quickly DKA can develop—and how often early warning signs or opportunities to measure...
MiniMed now shipping new MiniMed Flex
August 19, 2026HME News Staff
NORTHRIDGE, Calif. – MiniMed’s MiniMed Flex system is now commercially shipping in the U.S. with the Instinct sensor, made by Abbott. For the first time, people with diabetes can use MiniMed's smallest and only app-controlled insulin pump with Abbott's smallest sensor, with up to 15 days of wear. "People with diabetes deserve technology that works hard without asking much in return," said Que Dallara, CEO at MiniMed. "That's what we're delivering with MiniMed...
In brief: Memorial Hermann taps DASCO, Abbott partners with Google, Kalogon ramps up sales
August 14, 2026HME News Staff
HOUSTON – Memorial Hermann Health System and DASCO Home Medical Equipment have formed a joint venture to operate and expand the health system’s existing home medical equipment business.
The new company, DASCO | Memorial Hermann Home Medical Equipment, combines Memorial Hermann's clinical leadership and commitment to personalized care with DASCO's specialized operational experience in durable medical equipment (DME), the organizations say.
"Care does not end when a patient...
Abbott, Google partner to provide diabetes data, recommendations
August 13, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott has announced a partnership with Google Health to combine glucose insights from Abbott's Lingo biowearable with Google's expertise in artificial intelligence (AI) and consumer technology. The companies say the multi-year collaboration makes personalized metabolic insights more actionable, helping people take a more proactive approach to their health. "The biggest challenge in health care isn't treating disease – it's helping people stay...
In brief: Latest UHC-Synapse deal, Dexcom stolen sensors, WeOxy debut
May 29, 2026HME News Staff
SKOKIE, Ill. – UnitedHealthcare has announced that Synapse Health will manage durable medical equipment (DME) orders for certain UnitedHealthcare Medicare Advantage plans in additional states beginning Sept. 1, 2026.
For individual HMO & PPO plans, Synapse Health will manage DME for members in Connecticut, District of Columbia, Delaware, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania and Rhode Island.
For chronic special needs plans (C-SNP), Synapse...
Abbott secures European clearance for dual glucose/ketone device
May 27, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott has secured CE Mark for a dual glucose ketone sensing technology for people with diabetes. Branded as Libre Duo and Libre Duo 10 Day, the systems are designed to continuously measure glucose and ketone levels every minute, providing real-time visibility into both glucose levels needed for daily diabetes management and rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency. The company says this marks the first time people with diabetes will be able...